JPWO2023277122A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023277122A5 JPWO2023277122A5 JP2023532047A JP2023532047A JPWO2023277122A5 JP WO2023277122 A5 JPWO2023277122 A5 JP WO2023277122A5 JP 2023532047 A JP2023532047 A JP 2023532047A JP 2023532047 A JP2023532047 A JP 2023532047A JP WO2023277122 A5 JPWO2023277122 A5 JP WO2023277122A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 103
- 239000002253 acid Substances 0.000 claims 39
- 101100112922 Candida albicans CDR3 gene Proteins 0.000 claims 30
- 150000001413 amino acids Chemical class 0.000 claims 10
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 10
- 102000014914 Carrier Proteins Human genes 0.000 claims 6
- 108010090804 Streptavidin Proteins 0.000 claims 6
- 108091008324 binding proteins Proteins 0.000 claims 6
- 210000004899 c-terminal region Anatomy 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 238000001514 detection method Methods 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 238000002965 ELISA Methods 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000003118 sandwich ELISA Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025065498A JP2025108564A (ja) | 2021-07-01 | 2025-04-11 | ポリシアル酸又はポリシアル酸保持体の検出又は分離方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021110251 | 2021-07-01 | ||
| PCT/JP2022/026183 WO2023277122A1 (ja) | 2021-07-01 | 2022-06-30 | ポリシアル酸又はポリシアル酸保持体の検出又は分離方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025065498A Division JP2025108564A (ja) | 2021-07-01 | 2025-04-11 | ポリシアル酸又はポリシアル酸保持体の検出又は分離方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023277122A1 JPWO2023277122A1 (https=) | 2023-01-05 |
| JPWO2023277122A5 true JPWO2023277122A5 (https=) | 2024-02-01 |
Family
ID=84691903
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532047A Pending JPWO2023277122A1 (https=) | 2021-07-01 | 2022-06-30 | |
| JP2025065498A Pending JP2025108564A (ja) | 2021-07-01 | 2025-04-11 | ポリシアル酸又はポリシアル酸保持体の検出又は分離方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025065498A Pending JP2025108564A (ja) | 2021-07-01 | 2025-04-11 | ポリシアル酸又はポリシアル酸保持体の検出又は分離方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPWO2023277122A1 (https=) |
| WO (1) | WO2023277122A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3478717B1 (en) * | 2016-07-04 | 2022-01-05 | F. Hoffmann-La Roche AG | Novel antibody format |
| EP3765031A4 (en) * | 2018-03-14 | 2022-03-23 | Memorial Sloan Kettering Cancer Center | ANTI-POLYSIAL ACID ANTIBODIES AND USES THEREOF |
-
2022
- 2022-06-30 WO PCT/JP2022/026183 patent/WO2023277122A1/ja not_active Ceased
- 2022-06-30 JP JP2023532047A patent/JPWO2023277122A1/ja active Pending
-
2025
- 2025-04-11 JP JP2025065498A patent/JP2025108564A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014509853A5 (https=) | ||
| JP2016505634A5 (https=) | ||
| JP2021520492A5 (https=) | ||
| KR20210049894A (ko) | 항-인간 심근 트로포닌 i 재조합 항체 | |
| CN112740037A (zh) | 糖化血红蛋白(％)测定方法 | |
| EP3424942A1 (en) | Improved rep protein for use in a diagnostic assay | |
| JP5252339B2 (ja) | Ｐａｄ４及び抗ｐａｄ４抗体の測定方法並びに関節リウマチの検出方法 | |
| RU2019110953A (ru) | Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение | |
| JP5821198B2 (ja) | 抗ｉｌ２８ｂ抗体及びこれを用いたｉｌ２８ｂの測定方法 | |
| CN107110848B (zh) | 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法 | |
| JP5712513B2 (ja) | ヒトサイトメガロウイルス感染の検出方法 | |
| JP2022031783A (ja) | ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法 | |
| JPWO2023277122A5 (https=) | ||
| CN111234026A (zh) | 特异性结合脂阿拉伯甘露聚糖的单克隆抗体及其在分枝杆菌检测中的应用 | |
| Kierny et al. | Generating recombinant antibodies against putative biomarkers of retinal injury | |
| JP2010145238A (ja) | 抗膜貫通型タンパク質抗体の抗原結合部位を決定する方法 | |
| CN115812078A (zh) | 抗人类免疫缺陷病毒-1抗体及其使用方法 | |
| JP7366411B2 (ja) | ヒトαディフェンシンＨＤ５を検出する方法及びキット、並びにこれらにおいて用いられる抗体 | |
| CN115636879B (zh) | 一种基于二代测序和蛋白质组学的纳米抗体生产及其应用方法 | |
| JP7207517B2 (ja) | Ａｐｐ６６９－７１１の測定方法、及び測定用キット | |
| CN105884872B (zh) | LppZ抗体识别的抗原多肽及其用途 | |
| CN105486855B (zh) | 改良间接酶联免疫吸附法 | |
| WO2024011077A3 (en) | Monoclonal antibodies directed to phosphorylated psd95 and uses thereof | |
| JP6183920B2 (ja) | 腎炎の病変部位の検査方法およびそのための試薬 | |
| JP2024143793A5 (https=) |